Position in ABBV
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$2,585,349
+$366,299 QoQ
Shares Held
10,274
+0.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#1,753
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Nicholas Hoffman & Company, LLC. holds $35,503,201 across 12 Drug Manufacturers - General names. ABBV ranks #3 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
9,776 | $11,725,628 | |
| 2 | JNJ |
Johnson & Johnson
|
34,137 | $8,669,773 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
10,274 | $2,585,349 | |
| 4 | AZN |
Astrazeneca PLC
|
11,897 | $2,255,909 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
35,055 | $2,019,869 | |
| 6 | GSK |
GSK plc
|
37,580 | $1,969,943 | |
| 7 | MRK |
Merck & Co., Inc.
|
15,146 | $1,946,261 | |
| 8 | NVS |
Novartis AG
|
9,771 | $1,531,311 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,585,349 | 10,274 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $2,219,050 | 10,203 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $2,338,595 | 10,235 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $2,373,979 | 10,253 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,883,857 | 10,149 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $1,515,039 | 7,231 | Shares | Sole | 2025-06-23 | |
| 2024-12-31 | $1,400,453 | 7,881 | Shares | Sole | 2025-06-23 | |
| 2024-09-30 | $1,506,969 | 7,631 | Shares | Sole | 2025-06-23 | |
| 2024-06-30 | $1,314,700 | 7,665 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $1,395,068 | 7,661 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $1,186,760 | 7,658 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $1,094,249 | 7,341 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $1,015,594 | 7,538 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,255,835 | 7,880 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,273,001 | 7,877 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,057,574 | 7,880 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $1,193,269 | 7,791 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $1,275,157 | 7,866 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $1,094,709 | 8,085 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $877,198 | 8,132 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $802,672 | 7,126 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $770,634 | 7,121 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $724,548 | 6,762 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $526,415 | 6,010 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $535,768 | 5,457 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $704,909 | 9,252 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||